Agilent Suggests Own Audit Turned Up China Corruption Problems
This article was originally published in PharmAsia News
Executive Summary
Agilent Technologies may have become the latest multinational company to be drawn into China's healthcare corruption scandal, acknowledging its own internal audit turned up problems with third-party dealings.